RxDoctor Payments Data

Shahriar Shahzeidi, MD

Sleep Medicine · Leesburg, VANPI 1538192281

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Harmony Biosciences LLC accounts for 86.0% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $14,110, more than ten times the $311 reported in 2019. Among sleep medicine clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,863in general payments, 2019–2025

Across 235 payments — averaging $114.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Harmony Biosciences LLC$23K
  • Jazz Pharmaceuticals Inc.$2K
  • Baxter Healthcare$460
  • Advanced Respiratory, Inc$318
  • Avadel CNS Pharmaceuticals, LLC$283
  • Fisher & Paykel Healthcare Inc$246
  • plus $852 from 12 others

What the payments were for

  • Consulting fees$4,73818%
  • Speaking & faculty fees$13,74851%
  • Travel & lodging$9634%
  • Food & beverage$6,88026%
  • Education$5342%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,863 in reported general payments places this provider in the 90th percentile of 74 sleep medicine providers in Virginia.

See all sleep medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$90,723
Medicare patients
171
Services billed
421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide11$10,018
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,422
Arnuity ElliptaFluticasone Furoate35$7,314
EliquisApixaban12$6,708
Atrovent HfaIpratropium Bromide12$5,796
Scopolamine20$3,269
Azelastine-FluticasoneAzelastine/Fluticasone16$2,197
Eszopiclone66$1,536
Ventolin HfaAlbuterol Sulfate21$1,258
Montelukast Sodium25$437
Zaleplon17$251
Baclofen17$206
Hydroxyzine Pamoate23$174
Gabapentin13$17

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →